Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kundai Moyo"'
Autor:
Zhiyong Zhou, Kevin Tang, Guoqing Zhang, Nellie Wadonda-Kabondo, Kundai Moyo, Lori A. Rowe, Joshua R. DeVos, Nick Wagar, Du-Ping Zheng, Hongxiong Guo, John Nkengasong, Mike Frace, Scott Sammons, Chunfu Yang
Publikováno v:
African Journal of Laboratory Medicine, Vol 7, Iss 1, Pp e1-e9 (2018)
Background: Minority drug resistance mutations (DRMs) that are often missed by Sanger sequencing are clinically significant, as they can cause virologic failure in individuals treated with antiretroviral therapy (ART) drugs. Objective: This study ai
Externí odkaz:
https://doaj.org/article/13d0f9c6ea3b4931821b0e95467225c9
Autor:
Kundai Moyo, Carol Porter, Ben Chilima, Reuben Mwenda, Mark Kabue, Lutho Zungu, Abdoulaye Sarr
Publikováno v:
African Journal of Laboratory Medicine, Vol 4, Iss 1, Pp e1-e8 (2015)
Background: Malawi has a high burden of infectious disease. The expansion of programmes targeting these diseases requires a strong laboratory infrastructure to support both diagnosis and treatment.Objectives: To assess the use of laboratory test resu
Externí odkaz:
https://doaj.org/article/5d08df8a0b314e919fae05c9a241de9d
Autor:
Michele A Sinunu, Erik J Schouten, Nellie Wadonda-Kabondo, Enock Kajawo, Michael Eliya, Kundai Moyo, Frank Chimbwandira, Lee Strunin, Scott E Kellerman
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100741 (2014)
BACKGROUND: Prevention of mother-to-child transmission of HIV (PMTCT) programs can greatly reduce the vertical transmission rate (VTR) of HIV, and Malawi is expanding PMTCT access by offering HIV-infected pregnant women life-long antiretroviral thera
Externí odkaz:
https://doaj.org/article/77f02dbccb654a669a52406f9456c99b
Autor:
Hongxiong Guo, Lori A. Rowe, John N. Nkengasong, Kevin Tang, Kundai Moyo, Nellie Wadonda-Kabondo, Joshua DeVos, Du-Ping Zheng, Guoqing Zhang, Zhiyong Zhou, Nick Wagar, Mike Frace, Chunfu Yang, Scott Sammons
Publikováno v:
African Journal of Laboratory Medicine, Vol 7, Iss 1, Pp e1-e9 (2018)
African Journal of Laboratory Medicine
African Journal of Laboratory Medicine, Volume: 7, Issue: 1, Pages: 1-9, Published: 2018
African Journal of Laboratory Medicine
African Journal of Laboratory Medicine, Volume: 7, Issue: 1, Pages: 1-9, Published: 2018
Background: Minority drug resistance mutations (DRMs) that are often missed by Sanger sequencing are clinically significant, as they can cause virologic failure in individuals treated with antiretroviral therapy (ART) drugs. Objective: This study aim
Autor:
Mark Kabue, Kundai Moyo, Abdoulaye Dieng Sarr, Lutho I Zungu, Ben Chilima, Reuben Mwenda, Carol Porter
Publikováno v:
African Journal of Laboratory Medicine, Vol 4, Iss 1, Pp e1-e8 (2015)
African Journal of Laboratory Medicine
African Journal of Laboratory Medicine, Volume: 4, Issue: 1, Pages: 1-8, Published: 2015
African Journal of Laboratory Medicine
African Journal of Laboratory Medicine, Volume: 4, Issue: 1, Pages: 1-8, Published: 2015
Background: Malawi has a high burden of infectious disease. The expansion of programmes targeting these diseases requires a strong laboratory infrastructure to support both diagnosis and treatment.Objectives: To assess the use of laboratory test resu
Autor:
Michael Eliya, Lee Strunin, Nellie Wadonda-Kabondo, Enock Kajawo, Kundai Moyo, Frank Chimbwandira, Erik J Schouten, Scott E. Kellerman, Michele A. Sinunu
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100741 (2014)
PLoS ONE
PLoS ONE
Background Prevention of mother-to-child transmission of HIV (PMTCT) programs can greatly reduce the vertical transmission rate (VTR) of HIV, and Malawi is expanding PMTCT access by offering HIV-infected pregnant women life-long antiretroviral therap
Autor:
Nellie Wadonda-Kabondo, Michael R. Jordan, Maurice M’bang’ombe, Kundai Moyo, Richard Banda, Carol Porter, Mabvuto Chiwaula
In 2006, a survey of transmitted human immunodeficiency virus (HIV) drug resistance (TDR) was conducted in Lilongwe, Malawi. The survey followed the World Health Organization method to classify TDR to nucleoside reverse transcriptase inhibitors (NRTI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6124bd43982257eb16567f3e8bc8f28a
https://europepmc.org/articles/PMC3338309/
https://europepmc.org/articles/PMC3338309/
Autor:
Eddie Limbambala, George Bello, Erik J Schouten, Diane E Bennett, Michael R. Jordan, Anthony D. Harries, Bethany L. Hedt, John Aberle-Grasse, Kundai Moyo, Nellie Wadonda-Kabondo, Moses Massaquoi, Ben Chilima, Mina C. Hosseinipour, Storn Kabuluzi, Ralf Weigel, Carol Porter, Joep J. van Oosterhout
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limited treatment options, population-level surveillance of acquired human immunodeficiency virus drug resistance (HIVDR) is critical to ensuring long-term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cead55416cb63f93fe45afb414c917c4
https://europepmc.org/articles/PMC3338311/
https://europepmc.org/articles/PMC3338311/
Autor:
Ben Chilima, Blackson Matatiyo, Debbie Kamwendo, Austin Demby, Josh DeVos, Olesi Pasulani, Thomas R. Warne, Joep J. van Oosterhout, John Aberle-Grasse, Mina C. Hosseinipour, Richard Banda, Zhiyong Zhou, Diane E Bennett, Kundai Moyo, Clement Mtika, Carol Porter, Storn Kabuluzi, Mathew Kagoli, Chunfu Yang, Michael R. Jordan, Nellie Wadonda-Kabondo, Frank Chimbwandira, Andreas Jahn, Sam Phiri
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 54
Since 2004, the Malawi antiretroviral treatment (ART) program has provided a public health-focused system based on World Health Organization clinical staging, standardized first-line ART regimens, limited laboratory monitoring, and no patient-level m